Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
159.6 USD | -4.58% | -4.08% | +3.00% |
02:52pm | Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196 | MT |
02:31pm | Barclays Adjusts Price Target on AbbVie to $187 From $195 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.00% | 283B | |
+25.83% | 661B | |
+26.54% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+14.72% | 231B | |
+5.27% | 200B | |
-8.75% | 195B | |
-6.26% | 145B | |
-11.77% | 144B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing